The global stuttering therapeutics market, valued at USD 43 million in 2023, is on track for substantial growth, expected to expand at a CAGR of 14% from 2023 to 2033. By the end of this forecast period, the market is anticipated to reach a value of approximately USS 159.41 million. This growth follows a historical …